Retatrutide

Retatrutide (GIP/GLP-1/Glucagon Triple Agonist)

Triple incretin agonist targeting GIP, GLP-1, and glucagon receptors for advanced metabolic protocols.

Purity

99.0%

Form

Lyophilized Powder

CAS Number

2381272-96-2

Storage

-20°C, protected from light

Overview

Retatrutide is a novel triple agonist of GIP, GLP-1, and glucagon receptors. Its triagonist mechanism produces superior weight reduction and metabolic outcomes compared to dual or single agonists. For use exclusively in licensed clinical metabolic protocols under physician supervision.

Research Applications

Advanced weight management protocols

Triple incretin receptor research

Metabolic syndrome treatment

Cardiovascular risk reduction

Non-alcoholic steatohepatitis (NASH) research

Technical Specifications

Molecular FormulaC272H414N68O82

Molecular Weight5765.55 g/mol

CAS Number2381272-96-2

SequenceTriple agonist: GIP, GLP-1, and glucagon receptors

AppearanceWhite lyophilized powder

ReconstitutionBacteriostatic water

Storage-20°C, protected from light

COA Available

Lot-specific Certificate of Analysis available upon request for all approved wholesale accounts. Includes HPLC and mass spectrometry data.

Request COA

Quality Standards

GMP-certified synthesis

Independent HPLC verification

Mass spectrometry confirmed

Lot-specific documentation

Wholesale Inquiry

Available to licensed medical providers only. Submit credentials to receive pricing and availability.

Request Access

Related Compounds — GLP-1 Receptor Agonists

Semaglutide

Semaglutide (GLP-1 Analog)

99.1%View

Tirzepatide

Tirzepatide (GIP/GLP-1 Dual Agonist)

99.2%View

Cagrilintide + Semaglutide

Cagrilintide + Semaglutide Combination (CagriSema)

99.0%View